Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Anyone seeking treatment for obesity, diabetes, or another medical condition should speak with a qualified healthcare professional about approved options and monitoring needs
This condition is the basis of a lawsuit filed in early August, which claims the drug makers failed to warn consumers
Key examples include: Stimulant-containing supplements (caffeine, synephrine, yohimbine) should be avoided by people taking MAOIs or with uncontrolled hypertension Glucomannan may reduce the absorption of oral medicines
doi:10.1080/10606820213687
US$ 28.00
US$ 26.01
US$ 24.05
US$ 22.39
